Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 10.68 CHF -2.02%
Market Cap: 440.7m CHF
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 19.38 CHF with a low forecast of 18.18 CHF and a high forecast of 21 CHF.

MEDX Lowest Forecast
Wall Street Target
18.18 CHF
70% Upside
MEDX Average Forecast
Wall Street Target
19.38 CHF
81% Upside
MEDX Highest Forecast
Wall Street Target
21 CHF
97% Upside
Lowest
Price Target
18.18 CHF
70% Upside
Average
Price Target
19.38 CHF
81% Upside
Highest
Price Target
21 CHF
97% Upside
Medmix Ltd Competitors:
Price Targets
STE
STERIS plc
12% Upside
S
STIL
Stille AB
33% Upside
SGHT
Sight Sciences Inc
11% Downside
PRN
Profound Medical Corp
39% Upside
STE
STERIS plc
12% Upside
S
STIL
Stille AB
33% Upside
SGHT
Sight Sciences Inc
11% Downside
PRN
Profound Medical Corp
39% Upside
R
REG1V
Revenio Group Oyj
8% Upside
7817
Paramount Bed Holdings Co Ltd
2% Upside
ANGO
AngioDynamics Inc
47% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
6% Upside

Revenue
Forecast

Revenue Estimate
Medmix Ltd

For the last 5 years the compound annual growth rate for Medmix Ltd's revenue is 3%. The projected CAGR for the next 3 years is 4%.

3%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medmix Ltd

For the last 5 years the compound annual growth rate for Medmix Ltd's operating income is -19%. The projected CAGR for the next 3 years is 31%.

-19%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medmix Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall Street Estimates
MEDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDX's stock price target?
Price Target
19.38 CHF

According to Wall Street analysts, the average 1-year price target for MEDX is 19.38 CHF with a low forecast of 18.18 CHF and a high forecast of 21 CHF.

What is Medmix Ltd's Revenue forecast?
Projected CAGR
4%

For the last 5 years the compound annual growth rate for Medmix Ltd's revenue is 3%. The projected CAGR for the next 3 years is 4%.

What is Medmix Ltd's Operating Income forecast?
Projected CAGR
31%

For the last 5 years the compound annual growth rate for Medmix Ltd's operating income is -19%. The projected CAGR for the next 3 years is 31%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.